2023 Q1 Form 10-K Financial Statement
#000156459023002128 Filed on February 21, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $12.19M | $21.55M | $485.4M |
YoY Change | -96.15% | -84.54% | 29.38% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $18.91M | $15.71M | $66.76M |
YoY Change | 13.63% | 6.72% | 36.9% |
% of Gross Profit | |||
Research & Development | $52.65M | $28.25M | $107.9M |
YoY Change | 99.68% | 64.13% | 73.82% |
% of Gross Profit | |||
Depreciation & Amortization | $2.900M | $13.79M | $9.000M |
YoY Change | 107.14% | 247.02% | 104.55% |
% of Gross Profit | |||
Operating Expenses | $77.07M | $59.32M | $268.9M |
YoY Change | -15.9% | 2.67% | 333.3% |
Operating Profit | -$64.87M | $216.5M | |
YoY Change | -128.84% | 5.92% | |
Interest Expense | $9.759M | $12.03M | $12.03M |
YoY Change | 713.25% | -537.6% | -537.6% |
% of Operating Profit | 5.56% | ||
Other Income/Expense, Net | $16.73M | -$5.668M | $22.59M |
YoY Change | 185.48% | -195.95% | 29.18% |
Pretax Income | -$48.15M | -$31.41M | $239.1M |
YoY Change | -120.86% | -137.08% | 9.1% |
Income Tax | -$8.038M | -$1.519M | $80.58M |
% Of Pretax Income | 33.7% | ||
Net Earnings | -$40.11M | -$29.89M | $158.5M |
YoY Change | -123.79% | -149.86% | 3.29% |
Net Earnings / Revenue | -328.99% | -138.75% | 32.66% |
Basic Earnings Per Share | -$0.14 | $0.56 | |
Diluted Earnings Per Share | -$0.14 | -$0.10 | $0.50 |
COMMON SHARES | |||
Basic Shares Outstanding | 287.7M | 286.1M | 285.1M |
Diluted Shares Outstanding | 287.8M shares | 314.8M |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $193.0M | $544.9M | $386.5M |
YoY Change | -64.63% | -24.63% | -18.82% |
Cash & Equivalents | $193.0M | $44.90M | $386.5M |
Short-Term Investments | $603.5M | $500.0M | $500.0M |
Other Short-Term Assets | $99.16M | $75.41M | $34.06M |
YoY Change | 242.84% | 254.93% | 12.45% |
Inventory | $1.447M | $1.532M | $1.532M |
Prepaid Expenses | |||
Receivables | $623.5M | $538.5M | $538.5M |
Other Receivables | $79.57M | $64.82M | $64.82M |
Total Short-Term Assets | $940.7M | $1.025B | $1.025B |
YoY Change | -19.9% | 10.29% | 10.29% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $233.2M | $217.3M | $217.3M |
YoY Change | 91.06% | 94.65% | 94.65% |
Goodwill | $47.81M | $47.81M | |
YoY Change | 0.0% | 0.0% | |
Intangibles | $128.8M | $131.5M | |
YoY Change | -11.62% | -11.38% | |
Long-Term Investments | $57.58M | $72.52M | $72.52M |
YoY Change | -2.21% | 44.14% | 44.14% |
Other Assets | $89.85M | $46.33M | $46.33M |
YoY Change | 107.07% | 51.2% | 51.2% |
Total Long-Term Assets | $557.3M | $515.4M | $515.4M |
YoY Change | 33.35% | 32.58% | 32.58% |
TOTAL ASSETS | |||
Total Short-Term Assets | $940.7M | $1.025B | $1.025B |
Total Long-Term Assets | $557.3M | $515.4M | $515.4M |
Total Assets | $1.498B | $1.541B | $1.541B |
YoY Change | -5.93% | 16.86% | 16.86% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $17.57M | $14.83M | $14.83M |
YoY Change | 69.72% | -0.64% | -0.64% |
Accrued Expenses | $5.868M | $0.00 | $5.583M |
YoY Change | 52.88% | ||
Deferred Revenue | $11.81M | $21.61M | |
YoY Change | 28.48% | 186.78% | |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $89.59M | $118.3M | $118.3M |
YoY Change | -58.02% | -1.95% | -1.95% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $2.962M | $3.086M | $156.1M |
YoY Change | -13.64% | 78.07% | 15.83% |
Total Long-Term Liabilities | $199.8M | $189.3M | $156.1M |
YoY Change | 16.61% | 9.96% | 15.83% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $89.59M | $118.3M | $118.3M |
Total Long-Term Liabilities | $199.8M | $189.3M | $156.1M |
Total Liabilities | $289.4M | $307.6M | $307.6M |
YoY Change | -24.78% | 5.05% | 5.05% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $386.1M | $426.2M | |
YoY Change | -11.5% | 59.22% | |
Common Stock | $824.4M | $808.5M | |
YoY Change | 7.0% | 6.69% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.209B | $1.233B | $1.233B |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.498B | $1.541B | $1.541B |
YoY Change | -5.93% | 16.86% | 16.86% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$40.11M | -$29.89M | $158.5M |
YoY Change | -123.79% | -149.86% | 3.29% |
Depreciation, Depletion And Amortization | $2.900M | $13.79M | $9.000M |
YoY Change | 107.14% | 247.02% | 104.55% |
Cash From Operating Activities | -$44.06M | $30.91M | $277.4M |
YoY Change | -143.97% | -284.97% | 13.4% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $14.98M | $12.33M | $70.66M |
YoY Change | 3.37% | -230.75% | -220.89% |
Acquisitions | $0.00 | ||
YoY Change | -100.0% | ||
Other Investing Activities | -$134.6M | -$4.733M | -$280.0M |
YoY Change | 1033.59% | -157.15% | 2.25% |
Cash From Investing Activities | -$149.6M | -$17.06M | -$352.6M |
YoY Change | 467.32% | 1385.03% | 6.13% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$458.0K | 349.0K | -1.628M |
YoY Change | -85.37% | -80.97% | -58.11% |
NET CHANGE | |||
Cash From Operating Activities | -$44.06M | 30.91M | 277.4M |
Cash From Investing Activities | -$149.6M | -17.06M | -352.6M |
Cash From Financing Activities | -$458.0K | 349.0K | -1.628M |
Net Change In Cash | -$194.3M | 14.20M | -86.49M |
YoY Change | -375.61% | -188.59% | -6.97% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$44.06M | $30.91M | $277.4M |
Capital Expenditures | $14.98M | $12.33M | $70.66M |
Free Cash Flow | -$59.05M | $18.58M | $206.7M |
YoY Change | -168.88% | -355.18% | -31.79% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-39781 | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
A1 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2215 Yukon Street | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Vancouver | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
BC | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Auditor Name
AuditorName
|
KPMG LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Vancouver, Canada | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
476142000 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
386535000 | |
CY2021Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
246835000 | |
CY2021Q4 | abcl |
Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
|
722977000 | |
CY2021Q4 | abcl |
Accounts And Accrued Receivable Current
AccountsAndAccruedReceivableCurrent
|
160576000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
118918000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10252000 | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
275763745 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.48 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
285056606 | |
CY2020 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
263129765 | |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
318294236 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
314827255 | |
CY2020 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
36412000 | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
41848000 | |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
29240000 | |
CY2021Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
||
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
||
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
V5Y 0A1 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
604 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
559-9005 | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
ABCL | |
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
Yes | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
true | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
2404551632000 | |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
287686199 | |
CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
189310000 | |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
292836000 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
307630000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
283257104 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
283257104 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
286851595 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
286851595 | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
722430000 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
734365000 | |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
35357000 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
74118000 | |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
280000 | |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1391000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
267666000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
426185000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1025733000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1233277000 | |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1318569000 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1540907000 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
233155000 | |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
375203000 | |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
485424000 | |
CY2020 | us-gaap |
Royalty Expense
RoyaltyExpense
|
27143000 | |
CY2021 | us-gaap |
Royalty Expense
RoyaltyExpense
|
45516000 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001703057 | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
00-0000000 | |
CY2021 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
CY2022 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
0 | |
CY2022 | us-gaap |
Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
|
http://fasb.org/us-gaap/2022#OperatingExpenses | |
CY2022Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | |
CY2021Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | |
CY2021Q4 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
0 | |
CY2022Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
||
CY2022Q4 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
CY2022 | us-gaap |
Royalty Expense
RoyaltyExpense
|
66436000 | |
CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
29393000 | |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
62062000 | |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
107879000 | |
CY2020 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
3842000 | |
CY2021 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
6913000 | |
CY2022 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
11270000 | |
CY2020 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11910000 | |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
55485000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilities | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilities | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
AbCellera Biologics Inc. | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common shares, no par value per share | |
CY2020 | abcl |
Depreciation Amortization And Impairment
DepreciationAmortizationAndImpairment
|
4836000 | |
CY2021 | abcl |
Depreciation Amortization And Impairment
DepreciationAmortizationAndImpairment
|
14451000 | |
CY2022 | abcl |
Depreciation Amortization And Impairment
DepreciationAmortizationAndImpairment
|
27843000 | |
CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
77124000 | |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
170790000 | |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
268913000 | |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
156031000 | |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
204413000 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
216511000 | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
85 | |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
499950000 | |
CY2022Q4 | abcl |
Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
|
886485000 | |
CY2022Q4 | abcl |
Accounts And Accrued Receivable Current
AccountsAndAccruedReceivableCurrent
|
38593000 | |
CY2021Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
25000000 | |
CY2022Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
25000000 | |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
21247000 | |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
75413000 | |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
929800000 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1025491000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
111616000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
217255000 | |
CY2021Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
148392000 | |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
131502000 | |
CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
47806000 | |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
47806000 | |
CY2021Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
50313000 | |
CY2022Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
72522000 | |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
30642000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
46331000 | |
CY2021Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
388769000 | |
CY2022Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
515416000 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
1318569000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
1540907000 | |
CY2021Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
32017000 | |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
33150000 | |
CY2021Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
22934000 | |
CY2022Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
44211000 | |
CY2021Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
35683000 | |
CY2021Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
22506000 | |
CY2022Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
19347000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
7536000 | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
21612000 | |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
120676000 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
118320000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
36413000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
76675000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
27409000 | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
19516000 | |
CY2021Q4 | abcl |
Deferred Grants Funding Noncurrent
DeferredGrantsFundingNoncurrent
|
33349000 | |
CY2022Q4 | abcl |
Deferred Grants Funding Noncurrent
DeferredGrantsFundingNoncurrent
|
40801000 | |
CY2021Q4 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
35886000 | |
CY2022Q4 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
16054000 | |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
37370000 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
33178000 | |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1733000 | |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
3086000 | |
CY2021Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
172160000 | |
CY2020 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
293000 | |
CY2021 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
3330000 | |
CY2022 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
16079000 | |
CY2020 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-6811000 | |
CY2021 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-6080000 | |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4045000 | |
CY2020 | abcl |
Grants And Incentives
GrantsAndIncentives
|
8320000 | |
CY2021 | abcl |
Grants And Incentives
GrantsAndIncentives
|
17486000 | |
CY2022 | abcl |
Grants And Incentives
GrantsAndIncentives
|
10554000 | |
CY2020 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1802000 | |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
14736000 | |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
22588000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
157833000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
219149000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
239099000 | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
38915000 | |
CY2022 | abcl |
Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Royalties Payable
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingRoyaltiesPayable
|
1066000 | |
CY2020 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-350000 | |
CY2021 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-778000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
65685000 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
80580000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
153464000 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
158519000 | |
CY2021 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
280000 | |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-1671000 | |
CY2020 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
118918000 | |
CY2021 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
153744000 | |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
156848000 | |
CY2020 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.53 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.56 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.56 | |
CY2020 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.45 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.50 | |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
159195023 | |
CY2020 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
74662000 | |
CY2020 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
942000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4127000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
118918000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
830508000 | |
CY2021 | abcl |
Stock Issued During Period Value Stock Options And Other
StockIssuedDuringPeriodValueStockOptionsAndOther
|
6566000 | |
CY2021 | abcl |
Adjustments To Additional Paid In Capital Reclassification Of Liability Classified Options
AdjustmentsToAdditionalPaidInCapitalReclassificationOfLiabilityClassifiedOptions
|
5675000 | |
CY2021 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
280000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
153464000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1025733000 | |
CY2022 | abcl |
Stock Issued And Restricted Stock Units Vested During Period Value Stock Options Exercised
StockIssuedAndRestrictedStockUnitsVestedDuringPeriodValueStockOptionsExercised
|
1215000 | |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
49481000 | |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-1671000 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
158519000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1233277000 | |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
118918000 | |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
153464000 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
158519000 | |
CY2020 | us-gaap |
Depreciation
Depreciation
|
2317000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
4403000 | |
CY2022 | us-gaap |
Depreciation
Depreciation
|
8953000 | |
CY2020 | abcl |
Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
|
2519000 | |
CY2021 | abcl |
Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
|
10062000 | |
CY2022 | abcl |
Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
|
18890000 | |
CY2020 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
435000 | |
CY2021 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
2785000 | |
CY2022 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
5259000 | |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8397000 | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
30646000 | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
49481000 | |
CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2098000 | |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-2018000 | |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-2114000 | |
CY2020 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-4707000 | |
CY2021 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-3570000 | |
CY2022 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-8547000 | |
CY2020 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
5467000 | |
CY2021 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
37386000 | |
CY2022 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
22715000 | |
CY2020 | abcl |
Increase Decrease In Accrued Royalties Receivable
IncreaseDecreaseInAccruedRoyaltiesReceivable
|
197553000 | |
CY2021 | abcl |
Increase Decrease In Accrued Royalties Receivable
IncreaseDecreaseInAccruedRoyaltiesReceivable
|
-59864000 | |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-3064000 | |
CY2020 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
21810000 | |
CY2021 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
8624000 | |
CY2022 | abcl |
Increase Decrease In Accrued Royalties Receivable
IncreaseDecreaseInAccruedRoyaltiesReceivable
|
-129171000 | |
CY2021 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-13530000 | |
CY2022 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-88609000 | |
CY2020 | abcl |
Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Royalties Payable
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingRoyaltiesPayable
|
6601000 | |
CY2021 | abcl |
Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Royalties Payable
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingRoyaltiesPayable
|
1400000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
501142000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
594116000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
501142000 | |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
6183000 | |
CY2020 | us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
27143000 | |
CY2021 | us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
-4637000 | |
CY2022 | us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
-3160000 | |
CY2020 | abcl |
Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
|
6763000 | |
CY2021 | abcl |
Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
|
-30718000 | |
CY2022 | abcl |
Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
|
-9264000 | |
CY2020 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-1466000 | |
CY2021 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
2603000 | |
CY2022 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-1689000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
22690000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
244584000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
277360000 | |
CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
9673000 | |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
58452000 | |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
70660000 | |
CY2020 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
5000000 | |
CY2022 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
2000000 | |
CY2021 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
274710000 | |
CY2022 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
763982000 | |
CY2021 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
27608000 | |
CY2022 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
510631000 | |
CY2021 | abcl |
Proceeds From Receipt Of Grant Funding
ProceedsFromReceiptOfGrantFunding
|
32621000 | |
CY2022 | abcl |
Proceeds From Receipt Of Grant Funding
ProceedsFromReceiptOfGrantFunding
|
16434000 | |
CY2020 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
87643000 | |
CY2021 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
11457000 | |
CY2020 | abcl |
Payments To Acquire Long Term Investments And Other Assets
PaymentsToAcquireLongTermInvestmentsAndOtherAssets
|
-1783000 | |
CY2021 | abcl |
Payments To Acquire Long Term Investments And Other Assets
PaymentsToAcquireLongTermInvestmentsAndOtherAssets
|
17534000 | |
CY2022 | abcl |
Payments To Acquire Long Term Investments And Other Assets
PaymentsToAcquireLongTermInvestmentsAndOtherAssets
|
17369000 | |
CY2020 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
19247000 | |
CY2021 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
30323000 | |
CY2022 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
25679000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-119780000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-332247000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-352625000 | |
CY2020 | abcl |
Repayment Of Long Term Debt And Contingent Consideration
RepaymentOfLongTermDebtAndContingentConsideration
|
19942000 | |
CY2021 | abcl |
Repayment Of Long Term Debt And Contingent Consideration
RepaymentOfLongTermDebtAndContingentConsideration
|
4373000 | |
CY2022 | abcl |
Repayment Of Long Term Debt And Contingent Consideration
RepaymentOfLongTermDebtAndContingentConsideration
|
323000 | |
CY2020 | abcl |
Proceeds From Debt And Exercise Of Stock Options
ProceedsFromDebtAndExerciseOfStockOptions
|
16490000 | |
CY2021 | abcl |
Proceeds From Debt And Exercise Of Stock Options
ProceedsFromDebtAndExerciseOfStockOptions
|
5487000 | |
CY2022 | abcl |
Proceeds From Debt And Exercise Of Stock Options
ProceedsFromDebtAndExerciseOfStockOptions
|
2755000 | |
CY2020 | abcl |
Proceeds From Convertible Debentures
ProceedsFromConvertibleDebentures
|
89990000 | |
CY2020 | abcl |
Payment Of Liability For In Licensing Agreement And Other
PaymentOfLiabilityForInLicensingAgreementAndOther
|
387000 | |
CY2021 | abcl |
Payment Of Liability For In Licensing Agreement And Other
PaymentOfLiabilityForInLicensingAgreementAndOther
|
5000000 | |
CY2022 | abcl |
Payment Of Liability For In Licensing Agreement And Other
PaymentOfLiabilityForInLicensingAgreementAndOther
|
4060000 | |
CY2020 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
522840000 | |
CY2020 | us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
74662000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
683653000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3886000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1628000 | |
CY2021 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-1425000 | |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-9599000 | |
CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
586563000 | |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-92974000 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-86492000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
414650000 | |
CY2022Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
3115000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
7553000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
594116000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
594116000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
501142000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
411535000 | |
CY2020 | abcl |
Non Cash Or Part Non Cash Acquisition Property And Equipment Purchases In Accounts Payable
NonCashOrPartNonCashAcquisitionPropertyAndEquipmentPurchasesInAccountsPayable
|
656000 | |
CY2021 | abcl |
Non Cash Or Part Non Cash Acquisition Property And Equipment Purchases In Accounts Payable
NonCashOrPartNonCashAcquisitionPropertyAndEquipmentPurchasesInAccountsPayable
|
5397000 | |
CY2022 | abcl |
Non Cash Or Part Non Cash Acquisition Property And Equipment Purchases In Accounts Payable
NonCashOrPartNonCashAcquisitionPropertyAndEquipmentPurchasesInAccountsPayable
|
5868000 | |
CY2020 | abcl |
Noncash Or Part Noncash Acquisition Right Of Use Assets Obtained In Exchange For Operating Lease Obligation
NoncashOrPartNoncashAcquisitionRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligation
|
1679000 | |
CY2021 | abcl |
Noncash Or Part Noncash Acquisition Right Of Use Assets Obtained In Exchange For Operating Lease Obligation
NoncashOrPartNoncashAcquisitionRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligation
|
36638000 | |
CY2022 | abcl |
Noncash Or Part Noncash Acquisition Right Of Use Assets Obtained In Exchange For Operating Lease Obligation
NoncashOrPartNoncashAcquisitionRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligation
|
50694000 | |
CY2020 | us-gaap |
Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
|
9060000 | |
CY2022 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">1. Nature of operations</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.4%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AbCellera Biologics Inc.’s (the “Company”) mission is to bring better antibody drugs to patients faster, solve long-standing problems, and transform how antibody drugs are discovered. The Company aims to bring antibody therapeutics from target to clinic by combining expertise, technologies, and infrastructure to build an engine for antibody drug discovery and development. The Company <span style="color:#000000;">uses the engine to work with partners to build a large and diversified portfolio of royalty (and equivalent) stakes in future antibody drugs</span>. The Company partners with companies of all sizes - from innovative biotechnology companies to leading pharmaceutical companies - propelling programs to the clinic, together.</p> | |
CY2020Q4 | us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
1-for-10 | |
CY2020Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.1 | |
CY2022Q4 | abcl |
Company Contributed Segregated Account Representing Loss
CompanyContributedSegregatedAccountRepresentingLoss
|
25000000.0 | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:1.69%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.4%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Areas of significant estimates include, but are not limited to, revenue recognition including estimated timing of completion of performance obligations and </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">determining whether an option for additional goods or services represents a material right, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the fair</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> value of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">acquired intangible assets, and </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">contingent consideration payable</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimates</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of stock-based compensation awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">facts</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and experience. Changes in estimates are recorded in the period in which they become known. Actual results could significantly differ from those estimates. </span></p> | |
CY2021Q4 | us-gaap |
Cash
Cash
|
100500000 | |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
375600000 | |
CY2021Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
25000000.0 | |
CY2022Q4 | us-gaap |
Cash
Cash
|
126200000 | |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
260300000 | |
CY2022Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
28100000 | |
CY2022Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
25000000.0 | |
CY2022Q4 | abcl |
Restricted Cash Current Other Current Assets
RestrictedCashCurrentOtherCurrentAssets
|
2200000 | |
CY2022Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
900000 | |
CY2021 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
500000 | |
CY2022 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
1700000 | |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
|
0 | |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
|
0 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
7007000 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
|
0.50 | |
CY2022Q4 | abcl |
Deferred Compensation Share Based Arrangements Liability Classified Noncurrent Outstanding
DeferredCompensationShareBasedArrangementsLiabilityClassifiedNoncurrentOutstanding
|
0 | |
CY2021Q4 | abcl |
Deferred Compensation Share Based Arrangements Liability Classified Noncurrent Outstanding
DeferredCompensationShareBasedArrangementsLiabilityClassifiedNoncurrentOutstanding
|
0 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
11710000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
118918000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
153464000 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
158519000 | |
CY2020 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
33817000 | |
CY2020 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
85101000 | |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
153464000 | |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
158519000 | |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
159195023 | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
275763745 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
285056606 | |
CY2020 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.53 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.56 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.56 | |
CY2020 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
118918000 | |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
153464000 | |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
158519000 | |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
159195023 | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
275763745 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
285056606 | |
CY2020 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
63260090 | |
CY2020 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
40674652 | |
CY2021 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
42530491 | |
CY2022 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
29770649 | |
CY2020 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
263129765 | |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
318294236 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
314827255 | |
CY2020 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.45 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.48 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.50 | |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
908409 | |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11824006 | |
CY2020 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-680000 | |
CY2021Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
14282000 | |
CY2022Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
64817000 | |
CY2021Q4 | abcl |
Prepaid Expense And Other Current
PrepaidExpenseAndOtherCurrent
|
5293000 | |
CY2022Q4 | abcl |
Prepaid Expense And Other Current
PrepaidExpenseAndOtherCurrent
|
9064000 | |
CY2021Q4 | abcl |
Materials And Supplies Current
MaterialsAndSuppliesCurrent
|
1672000 | |
CY2022Q4 | abcl |
Materials And Supplies Current
MaterialsAndSuppliesCurrent
|
1532000 | |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
21247000 | |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
75413000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
121442000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
235730000 | |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
9826000 | |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
18475000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
111616000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
217255000 | |
CY2021Q4 | abcl |
Building And Leasehold Improvements Include Construction And Tenant Improvements Gross
BuildingAndLeaseholdImprovementsIncludeConstructionAndTenantImprovementsGross
|
19800000 | |
CY2022Q4 | abcl |
Building And Leasehold Improvements Include Construction And Tenant Improvements Gross
BuildingAndLeaseholdImprovementsIncludeConstructionAndTenantImprovementsGross
|
25600000 | |
CY2020 | us-gaap |
Depreciation
Depreciation
|
2300000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
4400000 | |
CY2022 | us-gaap |
Depreciation
Depreciation
|
9000000.0 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
160973000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
12581000 | |
CY2021Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
148392000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
154583000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
23081000 | |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
131502000 | |
CY2020 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2500000 | |
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10100000 | |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10500000 | |
CY2022 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
8400000 | |
CY2022 | abcl |
Impairment Of Intangible Assets Finite Lived Net Of Deferred Income Tax
ImpairmentOfIntangibleAssetsFiniteLivedNetOfDeferredIncomeTax
|
6300000 | |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
5007000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
8318000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
10625000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
5810000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
4241000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
4241000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
4241000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
29158000 | |
CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
31500000 | |
CY2021 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
16306000 | |
CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
47806000 | |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
47806000 | |
CY2022 | abcl |
Number Of Joint Ventures
NumberOfJointVentures
|
2 | |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
14924000 | |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
14828000 | |
CY2021Q4 | abcl |
Liability For In Licensing Agreement Current
LiabilityForInLicensingAgreementCurrent
|
4933000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3652000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5583000 | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4035000 | |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
6454000 | |
CY2021Q4 | abcl |
Deferred Grant Funding Current
DeferredGrantFundingCurrent
|
4473000 | |
CY2022Q4 | abcl |
Deferred Grant Funding Current
DeferredGrantFundingCurrent
|
6285000 | |
CY2021Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
32017000 | |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
33150000 | |
CY2021 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
283257104 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
283257104 | |
CY2022 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
286851595 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
286851595 | |
CY2022 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Each voting common share entitles the holder to one vote on all matters submitted to a vote of the Company’s shareholders. | |
CY2022 | us-gaap |
Dividends Cash
DividendsCash
|
0 | |
CY2021Q1 | abcl |
Conversion Of Liability Classified Options To Equity
ConversionOfLiabilityClassifiedOptionsToEquity
|
5700000 | |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8397000 | |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
30646000 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
49481000 | |
CY2022 | us-gaap |
Dividends
Dividends
|
0 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
34954000 | |
CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
41128000 | |
CY2020 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
3000000.0 | |
CY2021 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
4700000 | |
CY2022 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
11500000 | |
CY2020 | abcl |
Received Funding Commitment
ReceivedFundingCommitment
|
175600000 | |
CY2022 | abcl |
Received Funding Commitment
ReceivedFundingCommitment
|
129700000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
0 | |
CY2020 | abcl |
Strategic Innovation Fund Eligible Expenditure
StrategicInnovationFundEligibleExpenditure
|
12400000 | |
CY2021 | abcl |
Strategic Innovation Fund Eligible Expenditure
StrategicInnovationFundEligibleExpenditure
|
47100000 | |
CY2022 | abcl |
Strategic Innovation Fund Eligible Expenditure
StrategicInnovationFundEligibleExpenditure
|
18900000 | |
CY2020 | abcl |
Research And Development Eligible Expenditure
ResearchAndDevelopmentEligibleExpenditure
|
5300000 | |
CY2021 | abcl |
Research And Development Eligible Expenditure
ResearchAndDevelopmentEligibleExpenditure
|
13800000 | |
CY2022 | abcl |
Research And Development Eligible Expenditure
ResearchAndDevelopmentEligibleExpenditure
|
3900000 | |
CY2022 | abcl |
Capital Expenditures Incurred And Paid
CapitalExpendituresIncurredAndPaid
|
15000000.0 | |
CY2022 | abcl |
Capital Asset Expenditures Amortize Over Average Asset Life Period
CapitalAssetExpendituresAmortizeOverAverageAssetLifePeriod
|
P7Y | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.27 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.27 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
163077000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
211471000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
279771000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-5244000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
7678000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-40672000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
157833000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
219149000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
239099000 | |
CY2020 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
36931000 | |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
60498000 | |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
81392000 | |
CY2020 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
-114000 | |
CY2021 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
7248000 | |
CY2022 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
1300000 | |
CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
36817000 | |
CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
67746000 | |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
82692000 | |
CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2461000 | |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-1342000 | |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2322000 | |
CY2020 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-363000 | |
CY2021 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-719000 | |
CY2022 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-4434000 | |
CY2020 | abcl |
Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
|
2098000 | |
CY2021 | abcl |
Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
|
-2061000 | |
CY2022 | abcl |
Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
|
-2112000 | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
38915000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
65685000 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
80580000 | |
CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
36817000 | |
CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
67746000 | |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
82692000 | |
CY2020 | abcl |
Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
|
2098000 | |
CY2021 | abcl |
Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
|
-2061000 | |
CY2022 | abcl |
Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
|
-2112000 | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
38915000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
65685000 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
80580000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
157833000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
219149000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
239099000 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.27 | |
CY2020 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
42615000 | |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
59170000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
64557000 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
1934000 | |
CY2022 | abcl |
Income Tax Reconciliation Change In Tax Rate Differential
IncomeTaxReconciliationChangeInTaxRateDifferential
|
1911000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
36000 | |
CY2021 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
1000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
3529000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
1698000 | |
CY2021 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
4809000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
5908000 | |
CY2020 | abcl |
Effective Income Tax Rate Reconciliation At Foreign Exchange
EffectiveIncomeTaxRateReconciliationAtForeignExchange
|
-4048000 | |
CY2021 | abcl |
Effective Income Tax Rate Reconciliation At Foreign Exchange
EffectiveIncomeTaxRateReconciliationAtForeignExchange
|
47000 | |
CY2022 | abcl |
Effective Income Tax Rate Reconciliation At Foreign Exchange
EffectiveIncomeTaxRateReconciliationAtForeignExchange
|
536000 | |
CY2020 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
756000 | |
CY2021 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-738000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-251000 | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
38915000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
65685000 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
80580000 | |
CY2021Q4 | abcl |
Deferred Tax Assets Long Term Debt
DeferredTaxAssetsLongTermDebt
|
6293000 | |
CY2022Q4 | abcl |
Deferred Tax Assets Long Term Debt
DeferredTaxAssetsLongTermDebt
|
7695000 | |
CY2021Q4 | abcl |
Deferred Tax Assets Financing Fee
DeferredTaxAssetsFinancingFee
|
6575000 | |
CY2022Q4 | abcl |
Deferred Tax Assets Financing Fee
DeferredTaxAssetsFinancingFee
|
4827000 | |
CY2021Q4 | abcl |
Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
|
5299000 | |
CY2022Q4 | abcl |
Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
|
17355000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
4768000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
6042000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4996000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5054000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1807000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
3019000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
4696000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
30950000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
47476000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
3256000 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
6443000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
|
2135000 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
|
2007000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
36866000 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
32682000 | |
CY2021Q4 | abcl |
Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
|
4732000 | |
CY2022Q4 | abcl |
Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
|
16687000 | |
CY2021Q4 | abcl |
Deferred Tax Liabilities Government Funding Receivable
DeferredTaxLiabilitiesGovernmentFundingReceivable
|
3029000 | |
CY2022Q4 | abcl |
Deferred Tax Liabilities Government Funding Receivable
DeferredTaxLiabilitiesGovernmentFundingReceivable
|
1657000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
1661000 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
2437000 | |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
51679000 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
61913000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
20729000 | |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
14437000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
9233000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13411000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
29962000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
27848000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
21717000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
34065000 | |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
51679000 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
61913000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
29962000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
27848000 | |
CY2021Q4 | abcl |
Deferred Tax Assets Other Long Term Assets
DeferredTaxAssetsOtherLongTermAssets
|
7400000 | |
CY2022Q4 | abcl |
Deferred Tax Assets Other Long Term Assets
DeferredTaxAssetsOtherLongTermAssets
|
5300000 | |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
37400000 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
33200000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
9200000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13400000 | |
CY2022Q4 | us-gaap |
Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
|
7200000 | |
CY2022 | abcl |
Non Capital Loss And Investment Tax Credits Backup Period
NonCapitalLossAndInvestmentTaxCreditsBackupPeriod
|
P3Y | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
1500000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
18200000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
19400000 | |
CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
387000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
109000 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
109000 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
|
387000 | |
CY2021 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
|
109000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
109000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3652000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
5583000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
36413000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
76675000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
40065000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
82258000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
9610000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
9242000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
9132000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
8872000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
8857000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
65912000 | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P12Y1M6D | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.049 | |
CY2020 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
800000 | |
CY2021 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
3700000 | |
CY2022 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
7100000 | |
CY2020 | us-gaap |
Variable Lease Payment
VariableLeasePayment
|
300000 | |
CY2021 | us-gaap |
Variable Lease Payment
VariableLeasePayment
|
400000 | |
CY2022 | us-gaap |
Variable Lease Payment
VariableLeasePayment
|
1800000 | |
CY2020 | us-gaap |
Royalty Expense
RoyaltyExpense
|
27100000 | |
CY2021 | us-gaap |
Royalty Expense
RoyaltyExpense
|
45500000 | |
CY2022 | us-gaap |
Royalty Expense
RoyaltyExpense
|
66400000 | |
CY2021Q4 | abcl |
Accounts And Accrued Royalty Receivable Amounts Due Number Of Customers
AccountsAndAccruedRoyaltyReceivableAmountsDueNumberOfCustomers
|
13 | |
CY2022Q4 | abcl |
Accounts And Accrued Royalty Receivable Amounts Due Number Of Customers
AccountsAndAccruedRoyaltyReceivableAmountsDueNumberOfCustomers
|
21 | |
CY2021 | abcl |
Recognized Milestone Payments
RecognizedMilestonePayments
|
7000000.0 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
386500000 | |
CY2022Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
28100000 | |
CY2022Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
500000000.0 | |
CY2022Q4 | us-gaap |
Investment Interest Rate
InvestmentInterestRate
|
0.0100 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8200000 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
44900000 | |
CY2022Q4 | abcl |
Business Acquisitions Purchase Price Allocation Adjustments
BusinessAcquisitionsPurchasePriceAllocationAdjustments
|
0 |